Bruush Oral Care Inc.
BRSHW
NASDAQ Capital Market0.01
USD
+0.00
- -
CIK
0001913210
ISIN
CA11750K1205
Return %
Stock
S&P500
1Y
-74.90
26.57
3Y
-98.55
76.60
5Y
-98.55
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Aneil Singh Manhas
- Full Time Employees
- 11
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- 128 West Hastings Street Vancouver Canada V6B 1G8
- CIK
- 0001913210
- Website
- bruush.com
- Similar Companies
- Business
- Bruush Oral Care Inc. is an oral care company that manufactures and sells electric toothbrushes and related accessories through an e-commerce direct-to-consumer model, primarily in the United States and Canada; its core products include the Brüush starter kit comprising a sonic-powered electric toothbrush, three brush heads, a magnetic charging stand, USB power adapter, and travel case, as well as brush head refills available on a subscription basis every six months. Founded in 2018 and headquartered in Vancouver, British Columbia, Canada, the company targets millennials and Generation Z with premium oral care products aimed at improving accessibility to sonic cleaning technology and subscription-based refills. It operates in the dental equipment and supplies industry, with sales conducted via its website at www.bruush.com. In recent developments, Bruush Oral Care Inc. has faced significant challenges, including Nasdaq delisting proceedings initiated in 2024 due to failure to meet minimum bid price and stockholders' equity requirements, with trading suspended and the company now listed on OTC Markets under BRSHF and BRSHW; a proposed reverse merger with Arrive Technology Inc. announced in December 2023 was terminated in June 2024. The company announced in April 2025 plans to restate its 2022 financial statements following discovery of misappropriation of funds between November 2022 and May 2024, and it commenced litigation in early 2025 against former executives and a director alleging fraud and breach of fiduciary duty. Additional prior changes include a 1-for-25 reverse stock split in August 2023 to address Nasdaq compliance, appointment of Mandeek Manhas as CFO in 2023, and a $3.0 million private placement in December 2022.